Skip to main content
Tech.euFundingExplorerBeta

SV Health Investors’ Dementia Discovery Fund (DDF)

Investor profile

Venture capital

SV Health Investors’ Dementia Discovery Fund (DDF) has backed 1 European tech company across 1 funding round in 2025, joining rounds totalling €58M. Most active in Healthtech. Data as of Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2025
1 yr
Total round €
€58M
sum of rounds joined

Deals by year

distinct rounds / year
SV Health Investors’ Dementia Discovery Fund (DDF) — deals by year — interactive chart.
Data table
SV Health Investors’ Dementia Discovery Fund (DDF) — deals by year
20251

Top sectors

by deals
SV Health Investors’ Dementia Discovery Fund (DDF) — top sectors — interactive chart.
Data table
SV Health Investors’ Dementia Discovery Fund (DDF) — top sectors
Healthtech1

Stages

by deals
SV Health Investors’ Dementia Discovery Fund (DDF) — stages — interactive chart.
Data table
SV Health Investors’ Dementia Discovery Fund (DDF) — stages
Series B1

Countries

by deals
SV Health Investors’ Dementia Discovery Fund (DDF) — countries — interactive chart.
Data table
SV Health Investors’ Dementia Discovery Fund (DDF) — countries
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
SV Health Investors’ Dementia Discovery Fund (DDF) — 1 dealsSV Health Investors’ Dementia Discovery Fund (DDF)Brandon Capital — 1 shared deals · click to openBrandon CapitalBritish Business Bank — 1 shared deals · click to openBritish Business BankCriteria Bio Ventures — 1 shared deals · click to openCriteria Bio VenturesM Ventures — 1 shared deals · click to openM VenturesNovartis Venture Fund — 1 shared deals · click to openNovartis Venture FundOmega Funds — 1 shared deals · click to openOmega Funds

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
NRG TherapeuticsUK1€58M

Biggest deals

top 10 by amount
CompanyStageAmountDate
NRG TherapeuticsSeries B€58M2025-09
← Back to investors